An emerging and promising anticancer strategy: colonization of engineered <i>Staphylococcus epidermidis</i>

Yanyan Liu; Yulong Cai

doi:10.1002/mco2.467

PDF

MedComm ›› 2024, Vol. 5 ›› Issue (1) : e467. DOI: 10.1002/mco2.467

HIGHLIGHT

An emerging and promising anticancer strategy: colonization of engineered Staphylococcus epidermidis

Yanyan Liu¹ ,
Yulong Cai²

Author information +

History +

Cite this article

EndNote

Ris (Procite)

Bibtex

Download citation ▾

Yanyan Liu, Yulong Cai. An emerging and promising anticancer strategy: colonization of engineered Staphylococcus epidermidis. MedComm, 2024, 5(1): e467 https://doi.org/10.1002/mco2.467

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Chen YE, Bousbaine D, Veinbachs A, et al. Engineered skin bacteria induce antitumor T cell responses against melanoma. Science. 2023;380(6641):203-210. CrossRef Google scholar

[2]	Harris-Tryon TA, Grice EA. Microbiota and maintenance of skin barrier function. Science. 2022;376(6596):940-945. CrossRef Google scholar

[3]	Kepp O, Zitvogel L, Kroemer G. Prevention and treatment of cancers by tumor antigen-expressing Staphylococcus epidermidis. Oncoimmunology. 2023;12(1):2212547. CrossRef Google scholar

[4]	Naik S, Bouladoux N, Wilhelm C, et al. Compartmentalized control of skin immunity by resident commensals. Science. 2012;337(6098):1115-1119. CrossRef Google scholar

[5]	Severn MM, Horswill AR. Staphylococcus epidermidis and its dual lifestyle in skin health and infection. Nat Rev Microbiol. 2023;21(2):97-111. CrossRef Google scholar

RIGHTS & PERMISSIONS

2024 2024 The Authors. MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.